A high percentage of gastroparesis patients have difficulty with a variety of symptoms from abdominal pain to nausea and vomiting.
You might qualify for a clinical study for an investigational new medication for nausea and the symptoms of gastroparesis. The study duration is approximately 4 months with a screening phase of approximately one month prior to randomization to drug or placebo.
Qualified participants will receive study-related care and study medication at no charge as well as receive reimbursement for time and participation.
Contact Information
ICTS Research • 1031 Office Park Road, Suite 9 • West Des Moines, IA • www.ictsiowa.com
515-223-2300 • Ask for Jess or Shelby